PACS Group (PACS) director and 10% owner sells 13,628 shares under plan

Rhea-AI Filing Summary

PACS Group, Inc. director and ten percent owner Mark Hancock reported open-market sales of 13,628 shares of common stock on July 14 and 15, 2026. The shares were sold at weighted average prices of $45.0350 and $45.0525 per share under a Rule 10b5-1 trading plan adopted on March 11, 2026. Following these transactions, Hancock directly holds 53,906,884 shares of PACS Group common stock.

Insider Trade Summary 10b5-1

Net Seller: 13,628 shares ($613,795)

Net Sell 2 txns

Insider Hancock Mark

Role Director, 10% Owner

Sold 13,628 shs ($614K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,332	$45.0525	$150K
Sale	Common Stock	10,296	$45.035	$464K

Holdings After Transaction: Common Stock — 53,906,884 shares (Direct)

Footnotes (1)

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.1727 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Net shares sold: 13,628 shares July 14, 2026 sale: 10,296 shares at $45.0350 per share July 15, 2026 sale: 3,332 shares at $45.0525 per share +3 more

6 metrics

Net shares sold 13,628 shares Total common shares sold in open-market transactions reported in this Form 4

July 14, 2026 sale 10,296 shares at $45.0350 per share Open-market sale of PACS common stock on 2026-07-14

July 15, 2026 sale 3,332 shares at $45.0525 per share Open-market sale of PACS common stock on 2026-07-15

Shares owned after transactions 53,906,884 shares Direct PACS common stock holdings following the July 15, 2026 sale

Price range for July 15, 2026 trades $45.00–$45.1727 per share Weighted average price footnote for one sale day

Price range for July 14, 2026 trades $45.00–$45.07 per share Weighted average price footnote for one sale day

Key Terms

Rule 10b5-1 trading plan, weighted average price, open-market sale

3 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/16/2026 - 06:12 PM Accepted by SEC EDGAR 07/16/2026 - 06:12 PM Learn about SEC filing dates

FAQ

What insider transaction did PACS (PACS Group, Inc.) report for Mark Hancock?

PACS reported that Mark Hancock sold 13,628 shares of common stock in open-market transactions on July 14 and 15, 2026. These sales were executed under a Rule 10b5-1 trading plan, indicating they were pre-arranged rather than discretionary trades.

At what prices did Mark Hancock sell PACS (PACS Group, Inc.) shares?

Hancock’s PACS sales occurred at weighted average prices of $45.0350 and $45.0525 per share. The trades were broken into multiple transactions within ranges of $45.00–$45.07 and $45.00–$45.1727, respectively, as disclosed in the footnotes.

How many PACS (PACS Group, Inc.) shares did Mark Hancock sell on each date?

On July 14, 2026, Hancock sold 10,296 shares of PACS common stock. On July 15, 2026, he sold an additional 3,332 shares, bringing total reported sales in this Form 4 to 13,628 shares across the two days.

How many PACS (PACS Group, Inc.) shares does Mark Hancock own after these sales?

After the July 15, 2026 transaction, Hancock directly owns 53,906,884 shares of PACS common stock. The Form 4 identifies him as both a director and a ten percent owner, indicating a substantial continuing equity stake in the company.

Were Mark Hancock’s PACS (PACS Group, Inc.) stock sales under a Rule 10b5-1 plan?

Yes. The filing states the sales were made under a Rule 10b5-1 trading plan adopted by Hancock on March 11, 2026. Such plans pre-schedule trades, reducing the significance of trade timing as an indicator of management’s short-term views.

What type of transactions did PACS (PACS Group, Inc.) disclose for Mark Hancock in this Form 4?

PACS disclosed two open-market sales of common stock by Mark Hancock, both coded as “S” transactions. There were no option exercises, gifts, or tax-withholding entries reported, and no derivative securities transactions were included in this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hancock Mark

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/14/2026		S(1)		10,296	D	$45.035(2)	53,910,216	D
Common Stock	07/15/2026		S(1)		3,332	D	$45.0525(3)	53,906,884	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.

2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.1727 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)